i-SENS, Inc. (099190.KQ)
KRW 16060.0
(-3.37%)
KRW 16060.0
(-3.37%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 498.81 Billion KRW | 10.95% |
| 2022 | 449.57 Billion KRW | 4.75% |
| 2021 | 429.17 Billion KRW | 39.78% |
| 2020 | 307.03 Billion KRW | 13.7% |
| 2019 | 270.04 Billion KRW | 7.14% |
| 2018 | 252.04 Billion KRW | 7.68% |
| 2017 | 234.07 Billion KRW | 8.84% |
| 2016 | 215.06 Billion KRW | 17.37% |
| 2015 | 183.23 Billion KRW | 12.07% |
| 2014 | 163.51 Billion KRW | 15.62% |
| 2013 | 141.41 Billion KRW | 53.63% |
| 2012 | 92.04 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 555.24 Billion KRW | 11.33% |
| 2024 Q1 | 498.74 Billion KRW | -0.01% |
| 2023 Q4 | 498.81 Billion KRW | 0.12% |
| 2023 Q1 | 454.09 Billion KRW | 1.01% |
| 2023 Q2 | 457.88 Billion KRW | 0.84% |
| 2023 FY | 498.81 Billion KRW | 10.95% |
| 2023 Q3 | 498.24 Billion KRW | 8.81% |
| 2022 FY | 449.57 Billion KRW | 4.75% |
| 2022 Q1 | 448.1 Billion KRW | 4.41% |
| 2022 Q3 | 472.34 Billion KRW | 2.38% |
| 2022 Q4 | 449.57 Billion KRW | -4.82% |
| 2022 Q2 | 461.35 Billion KRW | 2.96% |
| 2021 FY | 429.17 Billion KRW | 39.78% |
| 2021 Q1 | 318.23 Billion KRW | 3.65% |
| 2021 Q2 | 324.14 Billion KRW | 1.86% |
| 2021 Q4 | 429.17 Billion KRW | 28.18% |
| 2021 Q3 | 334.83 Billion KRW | 3.3% |
| 2020 Q1 | 274.75 Billion KRW | 1.74% |
| 2020 Q3 | 301.43 Billion KRW | 8.48% |
| 2020 FY | 307.03 Billion KRW | 13.7% |
| 2020 Q4 | 307.03 Billion KRW | 1.85% |
| 2020 Q2 | 277.86 Billion KRW | 1.13% |
| 2019 Q1 | 258.9 Billion KRW | 2.72% |
| 2019 FY | 270.04 Billion KRW | 7.14% |
| 2019 Q3 | 280.53 Billion KRW | 4.66% |
| 2019 Q2 | 268.04 Billion KRW | 3.53% |
| 2019 Q4 | 270.04 Billion KRW | -3.74% |
| 2018 Q4 | 252.04 Billion KRW | 1.44% |
| 2018 Q1 | 238.44 Billion KRW | 1.87% |
| 2018 Q2 | 240.45 Billion KRW | 0.84% |
| 2018 FY | 252.04 Billion KRW | 7.68% |
| 2018 Q3 | 248.47 Billion KRW | 3.34% |
| 2017 Q4 | 234.07 Billion KRW | -1.07% |
| 2017 Q3 | 236.59 Billion KRW | 2.44% |
| 2017 Q1 | 212.77 Billion KRW | -1.07% |
| 2017 FY | 234.07 Billion KRW | 8.84% |
| 2017 Q2 | 230.97 Billion KRW | 8.55% |
| 2016 Q3 | 194.21 Billion KRW | 0.26% |
| 2016 FY | 215.06 Billion KRW | 17.37% |
| 2016 Q4 | 215.06 Billion KRW | 10.74% |
| 2016 Q2 | 193.71 Billion KRW | 4.35% |
| 2016 Q1 | 185.64 Billion KRW | 3.25% |
| 2015 Q2 | 171.14 Billion KRW | 3.19% |
| 2015 FY | 183.23 Billion KRW | 12.07% |
| 2015 Q1 | 165.85 Billion KRW | 1.43% |
| 2015 Q4 | 179.79 Billion KRW | 4.83% |
| 2015 Q3 | 171.52 Billion KRW | 0.22% |
| 2014 Q3 | 149.93 Billion KRW | 2.69% |
| 2014 FY | 163.51 Billion KRW | 15.62% |
| 2014 Q2 | 146 Billion KRW | 1.79% |
| 2014 Q4 | 163.51 Billion KRW | 9.05% |
| 2014 Q1 | 143.43 Billion KRW | 1.43% |
| 2013 Q1 | 109.13 Billion KRW | 18.56% |
| 2013 Q3 | 119.37 Billion KRW | 5.81% |
| 2013 Q4 | 141.41 Billion KRW | 18.46% |
| 2013 Q2 | 112.81 Billion KRW | 3.37% |
| 2013 FY | 141.41 Billion KRW | 53.63% |
| 2012 FY | 92.04 Billion KRW | 0.0% |
| 2012 Q4 | 92.04 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Osang Healthcare Co.,Ltd | 320.54 Billion KRW | -55.614% |
| InBody Co.,Ltd | 274.45 Billion KRW | -81.747% |
| Curexo Inc. | 107.36 Billion KRW | -364.579% |
| Seegene, Inc. | 1251.45 Billion KRW | 60.141% |
| Ray Co., Ltd. | 259.55 Billion KRW | -92.183% |
| Gencurix Inc. | 33.5 Billion KRW | -1388.919% |
| Sugentech Inc. | 133.18 Billion KRW | -274.523% |
| L&C Bio Co., Ltd | 262.23 Billion KRW | -90.221% |